Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Scheffler

Showing results (131-140 of 207) with videos related to

Pageof 21
Sort By:
Cancer Immunology, Immunotherapy : CII|November 9, 2019
Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancersAndreas Mock, Stefanie Zschäbitz, Romy Kirsten, et al.
Perfusion|August 11, 2017
International survey on the perioperative management of pulmonary endarterectomy: the perfusion perspectiveRoger D P Stanzel, Johannes Gehron, Matthias Wolff, et al.
Physical Review Letters|December 17, 2013
Space-charge transfer in hybrid inorganic-organic systemsYong Xu, Oliver T Hofmann, Raphael Schlesinger, et al.
Physical Review Letters|April 7, 2010
Alloy catalyst in a reactive environment: the example of ag-cu particles for ethylene epoxidationSimone Piccinin, Spiros Zafeiratos, Catherine Stampfl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinibCarsten Kobe, Matthias Scheffler, Arne Holstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PETDeniz Kahraman, Matthias Scheffler, Thomas Zander, et al.
Journal of Chemical Information and Modeling|September 7, 2018
AFLOW-CHULL: Cloud-Oriented Platform for Autonomous Phase Stability AnalysisCorey Oses, Eric Gossett, David Hicks, et al.
Physical Chemistry Chemical Physics : PCCP|February 21, 2015
Exploring the conformational preferences of 20-residue peptides in isolation: Ac-Ala19-Lys + H(+)vs. Ac-Lys-Ala19 + H(+) and the current reach of DFTFranziska Schubert, Mariana Rossi, Carsten Baldauf, et al.
MRS Bulletin|February 28, 2022
Materials genes of heterogeneous catalysis from clean experiments and artificial intelligenceLucas Foppa, Luca M Ghiringhelli, Frank Girgsdies, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2025
DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network-analysis plan of a prospective multicenter cohort trialAnika Kästner, Anna Kron, Leonie Eilers, et al.
Pageof 21

Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Cancer Immunology, Immunotherapy : CII|November 9, 2019
Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancersAndreas Mock, Stefanie Zschäbitz, Romy Kirsten, et al.
Perfusion|August 11, 2017
International survey on the perioperative management of pulmonary endarterectomy: the perfusion perspectiveRoger D P Stanzel, Johannes Gehron, Matthias Wolff, et al.
Physical Review Letters|December 17, 2013
Space-charge transfer in hybrid inorganic-organic systemsYong Xu, Oliver T Hofmann, Raphael Schlesinger, et al.
Physical Review Letters|April 7, 2010
Alloy catalyst in a reactive environment: the example of ag-cu particles for ethylene epoxidationSimone Piccinin, Spiros Zafeiratos, Catherine Stampfl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinibCarsten Kobe, Matthias Scheffler, Arne Holstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PETDeniz Kahraman, Matthias Scheffler, Thomas Zander, et al.
Journal of Chemical Information and Modeling|September 7, 2018
AFLOW-CHULL: Cloud-Oriented Platform for Autonomous Phase Stability AnalysisCorey Oses, Eric Gossett, David Hicks, et al.
Physical Chemistry Chemical Physics : PCCP|February 21, 2015
Exploring the conformational preferences of 20-residue peptides in isolation: Ac-Ala19-Lys + H(+)vs. Ac-Lys-Ala19 + H(+) and the current reach of DFTFranziska Schubert, Mariana Rossi, Carsten Baldauf, et al.
MRS Bulletin|February 28, 2022
Materials genes of heterogeneous catalysis from clean experiments and artificial intelligenceLucas Foppa, Luca M Ghiringhelli, Frank Girgsdies, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2025
DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network-analysis plan of a prospective multicenter cohort trialAnika Kästner, Anna Kron, Leonie Eilers, et al.
Pageof 21